OpenURL Connection Search

Select item for more details and to access through your institution.

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development.
Published in:
2012
By:
- Polonis, V.;
- Wieczorek, L.;
- Kalyanaraman, V.;
- Matyas, G.;
- Whitney, S.;
- Williams, C.;
- Tovanabutra, S.;
- Sanders-Buell, E.;
- Wesberry, M.;
- Ochsenbauer, C.;
- Chenine, A.;
- Rao, M.;
- Tong, T.;
- Alving, C.;
- Cheng, H.;
- Zolla-Pazner, S.;
- Michael, N.;
- VanCott, T.;
- Marovich, M.
Publication type:
Abstract
Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes.
Published in:
2012
By:
- Jain, S.;
- Ochsenbauer, C.;
- Kappes, J. C.;
- Rosenthal, K. L.
Publication type:
Abstract
Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells.
Published in:
2012
By:
- Sarzotti-Kelsoe, M.;
- Daniell, X.;
- Todd, C. A.;
- Bilska, M.;
- LaBranche, C.;
- Perez, L. G.;
- Ochsenbauer, C.;
- Kappes, J.;
- Rountree, W.;
- Ozaki, D. A.;
- Kim, J. H.;
- McLinden, R.;
- Denny, T.;
- Montefiori, D. C.
Publication type:
Abstract
Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial.
Published in:
2012
By:
- Williams, W. B.;
- Jones, K.;
- Krambrink, A.;
- Grove, D.;
- Liu, P.;
- Yates, N. L.;
- Moody, M. A.;
- Ferrari, G.;
- Pollara, J.;
- Moodie, Z.;
- Morgan, C. A.;
- H. Liao;
- Montefiori, D. C.;
- Ochsenbauer, C.;
- Kappes, J.;
- Hammer, S.;
- Mascola, J.;
- Koup, R.;
- Corey, L.;
- Nabel, G.
Publication type:
Abstract
Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.
Published in:
2012
By:
- Joachim, A.;
- Nilsson, C.;
- Aboud, S.;
- Lyamuya, E. F.;
- Robb, M.;
- Marovich, M.;
- Ochsenbauer, C.;
- Wahren, B.;
- Sandström, E.;
- Biberfeld, G.;
- Ferrari, G.;
- Polonis, V. R.
Publication type:
Abstract
Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes.
Published in:
2012
By:
- Pollara, J.;
- Bonsignori, M.;
- Moody, M.;
- Alam, M.;
- Liao, H.;
- Hwang, K.;
- Pickeral, J.;
- Kappes, J.;
- Ochsenbauer, C.;
- Soderberg, K.;
- Gurley, T. C.;
- Kozink, D. M.;
- Marshall, D. J.;
- Whitesides, J. F.;
- Montefiori, D.;
- Robinson, J. E.;
- Kaewkungwal, J.;
- Nitayaphan, S.;
- Pitisuttithum, P.;
- Rerks-Ngarm, S.
Publication type:
Abstract

Found: 6

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development.

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes.

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells.

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial.

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes.